The physiologic function of insulin in early embryonic life is unknown. We have shown that insulin is present in unfertilized eggs and in chick embryos at 2-3 days of development, even before the emergence of the endocrine pancreas. To define insulin's role, we exposed 2-day-old chick embryos to anti-insulin antibodies and followed their development up to day 5. Antibodytreated embryos had a higher rate of growth retardation and death by days 3-5 of embryogenesis, compared with controls. Among the survivors, biochemical maturation was delayed at days 4 and 5; weight, protein, total creatine kinase activity, and creatine kinase-MB were decreased in antibody-treated embryos.
To evaluate embryo maturation biochemically, we studied creatine kinase activity, which is found in abundance in skeletal and heart muscle and also occurs in brain and other tissues. 5 The change in the relative proportion of isozymes CK-BB (ubiquitous or embryonic) and CK-MB (more differentiated tissue form) is developmentally regulated 5 and inducible by insulin 6 and, therefore, a good marker for differentiation.
In the present study, we show that embryos at a prepancreatic stage (day 2) exposed to anti-insulin antibodies have an increased fatality rate. In the survivors, morphologic and biochemical development are retarded. Furthermore, in embryos at the same stage, insulin at low doses induces stimulatory changes opposite to those seen with anti-insulin antibodies.
MATERIALS AND METHODS
Chick embryos and injection procedure. Fertilized White Leghorn eggs were incubated at 38 ± 0.5°C and 70-80% relative humidity. At 2 days of development, a window was drilled in the shell over each embryo and embryos that were between developmental stages 10 and 14 of the Hamburger and Hamilton classification 4 were selected for study. The injection technique has been described elsewhere; 7 essentially, the volume of antibody (100 (xl) or insulin (50 |xl) was applied drop-wise onto the chorioallantoic membrane covering the entire embryo surface, and left in place for the duration of the experiment. Although this delivery system may appear to be subject to imprecision, we have obtained very reproducible effects, and it allows near-normal development in the majority of control embryos. Antibodies, peptides, and controls. Anti-insulin antiserum (lot 624, guinea pig antipork insulin antiserum, Department of Pharmacology, Indiana University, Indianapolis, Indiana) and control serum (normal guinea pig serum, Miles Research Laboratories, Elkhart, Indiana) were fractionated before administration. Whole serum was filtered on a protein-A Sepharose column; the eluted IgG was used for experiments at a final protein concentration of 4.0-4.8 mg/ml. The purified antibody had an insulin binding capacity of approximately 15 |xg/ml. In general, polyclonal antiporcine insulin antibodies recognize porcine, human, and bovine insulin very well, chicken insulin well, proinsulin less well, and they do not recognize insulin-like growth factors (IGFs) or other tissue growth factors. 38 Under radioimmunoassay conditions, we tested the ability of different peptides to displace a porcine insulin tracer bound to antibody #624. For it to compete as well as 10 pg chicken insulin we needed 100,000 pg of IGF-II (MSA, Sigma, St. Louis, Missouri).
In three additional experiments, insulin antiserum was further purified by affinity chromatography. Antiserum (2 ml) was treated with 40% ammonium sulfate; the precipitate was reconstituted in 2 ml barbital buffer (pH 8.8) containing 0.2% BSA, and applied to a column of Sepharose-4B to which porcine insulin had been covalently attached. After 3 days at 4°C the column was washed with PBS (pH 8) and the antibody eluted with HCI 1 N and 3 N containing 0.2% BSA. The eluate was neutralized, dialyzed against phosphate buffer, lyophilized, and reconstituted in distilled water. Despite having most of the protein, the flow-through did not bind 125 l-insulin under radioimmunoassay conditions, while the eluate showed a good recovery of the antibody.
Other antisera included antibody against epidermal growth factor, nerve growth factor (Collaborative Research, Waltham, Massachusetts), somatostatin (kind gift of Dr. Dorothy T. Krieger), substance P (kind gift of Dr. Susan E. Leeman), and TRH (kind gift of Dr. Krieger). These were purified by precipitation with 40% ammonium sulfate and dialysis before use. A comparable concentration (8-10 mg/ml) of fractionated normal guinea pig serum was used as control. NaCI were prepared before the injections. Analytical grade HCI appropriately diluted was used as control for insulin. Morphologic evaluation of embryos. Each embryo was evaluated under a stereomicroscope after 3, 4, and 5 days of development. When the heartbeat was not detected, the embryo was considered dead and was discarded. The live embryos were examined to assess the stage of development according to the classification of Hamburger and Hamilton. 4 The head, limb buds, tail, and extraembryonic vessels are the main morphologic features used to classify the embryo at these stages. 
9 Creatine kinase activity was measured spectrophotometrically at 340 nm (centrifugal Analyzer Centrifichem 400) after addition to CK-NAC-activated reagent (BoehringerMannheim, Indianapolis, Indiana) and 0.12 nM diadenosine pentaphosphate (myokinase inhibitor). The separation of BB and MB isoenzymes was carried out by continuous salt gradient elution from a 0.9 x 9-cm DEAE-Sepharose CL-6B column.
10 Samples of embryo homogenates containing approximately 6000 mil of creatine kinase (0.7-1.4 ml vol) were filtered on a column and 90 fractions eluted with a linear 0 -250 mM NaCI gradient (in Tris-HCI, 50 mM, pH 7.5). Creatine kinase activity was measured in individual fractions, and peaks corresponding to MB isozyme (elution at 55 mM Na + ) and BB isozyme (elution at 100 mM Na + ) were calculated. DNA and RNA contents were measured with ethidium bromide.
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RESULTS
Abnormal development and death rate after antibody treatment. The adminstration of protein-A-purified anti-insulin antibodies to day-2 embryos caused remarkably higher mortality than did normal IgG and, in survivors, produced macroscopic growth retardation at days 3, 4, and 5 ( Figure  1) . Among the survivors, the antibody-treated embryos showed a reduction in weight, total protein, and total creatine kinase by days 3 and 4 of development (Figure 2) . The proportion of the isozyme creatine kinase-MB relative to total enzyme activity was reduced in treated embryos at all ages studied (days 3-5). DNA and RNA contents were measured in live embryos at day 4. Prior treatment with anti-insulin antibody decreased both the content of DNA (to 73 ± 7% of control group, P < 0.05) and RNA (to 67 ± 7% of control group, P < 0.02).
Anti-insulin antibodies, purified further by affinity chromatography with insulin linked to Sepharose, were also applied to day-2 embryos. Again, we observed at day 4 the decrease in weight, total protein and creatine kinase-MB isozyme (Table 1). (Mortality was reduced to control levels possibly due to loss of antibody titer during purification.) The flow-through of the affinity column, which contained the bulk of the protein but none of the antibody, was without deleterious effect on the embryos.
To show that the effects were specific to anti-insulin antibodies, antisera to several growth factors and unrelated hormones were injected into eggs. There were no significant deleterious effects on growth between days 2 and 4 of embryogenesis when compared with effects of normal serum ( Table 2) . Effects of insulin. Application of purified insulin to day-2 embryos produced biochemical changes opposite to those elicited by the anti-insulin antibodies (Figure 2 ). Embryos treated with 50 ng of insulin had increased weight, protein, total creatine kinase, and creatine kinase-MB at days 3, 4, and 5 of development. The effects of insulin were dose-dependent in the range of 50-100 ng/embryo (Figure 3 ).
DISCUSSION
To elucidate the role of embryonic insulin, we exposed embryos at early stages to anti-insulin antibodies and to small doses of insulin. Development by morphologic and biochemical criteria was stopped or retarded by the antibodies and "mirror-like" stimulatory changes were observed with insulin. Thus, we raise the possibility that in young chick embryos insulin, or another peptide that is reactive with anti-insulin antibodies (but probably not IGFs, which react extremely weakly with anti-insulin antibodies), is required and contributes to some aspects of normal development. The insulin injection experiments are "phamnacologic" while the antiinsulin antibody injections provide "physiologic" insights. That the two sets of experiments yielded near-exact results is consistent with our suggestion that there is an endogenous insulin-related material that regulates development pathways. It should be emphasized that we do not yet know whether the effects we observe are exerted directly on the embryo's own tissue or at extraembryonic sites in the egg. While effects on extraembryonic membranes are possible, we do not think it is likely since the chorioallantoic membrane repeatedly had the lowest levels of binding of (unpublished data). Similarly, it is not known whether the effects we observe are primarily on "metabolic" pathways (e.g., glucose, lipid, and amino acid metabolism) and secondarily on the disruption of growth and development, or whether the effects are directly on "growth" pathways. In the case of the latter, the effects may be directly on development processes or largely on the inhibition of formation or release of growth factors such as the IGFs. In older mammals, production of IGFs and expression of IGF receptors in some circumstances are insulin-dependent processes.' 2 While the pathway is uncertain, it should be emphasized again that the primary molecular target of the antibody is insulin or a very close relative. In preliminary experiments, we have found that the deleterious effects of anti-insulin antibody are still demonstrable when we inject 50 ng/embryo of IGF-I (AmGen) together with the anti-insulin antibody, whereas added insulin abolishes most of the deleterious effects of the antibody (results not shown).
The prevailing feeling among developmental biologists seems to be that hormonal influences on embryonic development start late, 13 largely because the usual focus of hormone production is the endocrine gland and these glands appear at relatively advanced states of differentiation. The finding that insulin, presumably derived from sources outside the embryo's beta cells, plays an important role in the early embryo raises the possibility that nontraditional sources of hormone may be physiologically significant (in addition to any contribution from the emerging beta cells). Interestingly, prothoracicotrophic hormone, the brain peptide of insects that drives metamorphosis, has substantial structural similarity to insulin and insulin-like growth factor I, 14 although it does not react with anti-insulin antibodies. Among vertebrates, insulin stimulates differentiation in several embryonic cell types in culture, including myoblasts, which express creatine kinase-MB isozyme, 6 neurons. 15 and whole oocytes. 1617 Certainly, at later stages of embryogenesis insulin has been shown to have typical metabolic 1819 and growth-promoting effects. 2021 Insulin-(and proinsulin-) related molecules can act through insulin receptors to produce both metabolic and growth effects, or, less effectively, through type 1 receptors for IGFs. The present study sheds no light on which receptors are involved. We have found that IGF-type 1 receptors are the dominant binders for insulin, at least in brain, in embryos at early stages. 22 Autoradiographic studies with a detailed search for insulin and IGF receptors at early stages of embryogenesis, and the use of receptor
